Age, mean ± SD, yr | 63.8 ± 12.3 | 62.6 ± 14.8 | -1.2 (-1.7 to -0.6) |
Men | 2795 (69.9) | 3935 (70.5) | 0.6 (-1.2 to 2.5) 0.6% |
Location | | | |
Calgary | 1924 (48.1) | 2300 (41.2) | -6.9 (-8.9 to -4.9) |
Edmonton | 1706 (42.6) | 2633 (47.2) | 4.6 (2.5 to 6.6) |
Comorbid condition | APPROACH | DAD | APPROACH | DAD | APPROACH | DAD |
Hyperlipidemia | 2779 (69.4) | 1912 (47.8) | 3393 (60.8) | 660 (11.8) | -8.7 (-10.6 to -6.8) | -36.0 (-37.7 to -34.2) |
Heart failure | 456 (11.4) | 730 (18.2) | 449 (8.0) | 985 (17.6) | -3.3 (-4.6 to -2.2) | -0.6 (-2.2 to 1.0) |
Cerebrovascular disease | 234 (5.8) | 150 (3.7) | 253 (4.5) | 98 (1.8) | -1.3 (-2.2 to -0.4) | -2.0 (-2.7 to -1.3) |
Peripheral vascular disease | 290 (7.2) | 250 (6.2) | 159 (2.8) | 360 (6.4) | -4.4 (-5.3 to -3.5) | 0.2 (-0.8 to 1.2) |
Chronic obstructive pulmonary disease | 552 (13.8) | 434 (10.8) | 800 (14.3) | 512 (9.2) | 0.6 (-0.9 to 1.9) | -1.7 (-2.9 to -0.4) |